Percheron Therapeutics LimitedASX: PER

Letter From The Chair and Half Year Accounts

· Issued by Percheron Therapeutics Limited

Filed with ASX · · 26 pages · English

Although it is not our usual practice to accompany the half-year report with a Board communication, I thought it important under the circumstances to add some general comments to the accompanying financial statements. It would be an understatement to note that the last two months have been an exceptionally challenging period for Percheron and its shareholders. The negative data read-out from the a

Percheron Therapeutics Limited on 6ix

Story so far

Earlier from Percheron Therapeutics

Later from Percheron Therapeutics

All Percheron Therapeutics news releases